Company / Revenue
Haemonetics Revenue History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$1.3B
FY2026
5-year range
$1.2B / $1.4B
FY2022-FY2026
Trend
-
vs FY2025
Sector context
#95 of 156
Health Care
What the data says
At $1.3B, Haemonetics's revenue ranks #95 of 156 in the Health Care sector.
Based on SEC 10-K filings.
$1.3B in FY2026 with a 5-year CAGR of +5.7%.
Remained stable around $1.3B over the past 3 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- +5.7%
- 10-Year CAGR
- -
Sector benchmark
#95 of 156 in Health CareTop 61% of 156This company $1.3B Sector average $19.0B
▼
-93.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +5.7%, indicating consistent growth.
- Ranks #95 out of 156 companies in the Health Care sector.
- Peak revenue was recorded in FY2024.
- Lowest revenue in the period was in FY2017.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $1.3B | - |
| FY2025 | - | - |
| FY2024 | $1.4B | +4.0% |
| FY2023 | $1.3B | +12.0% |
| FY2022 | $1.2B | +17.7% |
| FY2021 | $993.2M | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $225.4M | -74.6% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026